<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37280412</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-0973</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Infection</Title><ISOAbbreviation>Infection</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022.</ArticleTitle><Pagination><StartPage>1531</StartPage><EndPage>1539</EndPage><MedlinePgn>1531-1539</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s15010-023-02052-5</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The study evaluates the effects on sero-immunity, health status and quality of life of children and adolescents after the upsurge of the Omicron variant in Germany.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This multicenter cross-sectional study (IMMUNEBRIDGE Kids) was conducted within the German Network University Medicine (NUM) from July to October 2022. SARS-CoV-2- antibodies were measured and data on SARS-CoV-2 infections, vaccinations, health and socioeconomic factors as well as caregiver-reported evaluation on their children's health and psychological status were assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">497 children aged 2-17&#xa0;years were included. Three groups were analyzed: 183 pre-schoolchildren aged 2-4&#xa0;years, 176 schoolchildren aged 5-11&#xa0;years and 138 adolescents aged 12-18&#xa0;years. Positive antibodies against the S- or N-antigen of SARS-CoV-2 were detected in 86.5% of all participants (70.0% [128/183] of pre-schoolchildren, 94.3% of schoolchildren [166/176] and 98.6% of adolescents [136/138]). Among all children, 40.4% (201/497) were vaccinated against COVID-19 (pre-schoolchildren 4.4% [8/183], schoolchildren 44.3% [78/176] and adolescents 83.3% [115/138]). SARS-CoV-2 seroprevalence was lowest in pre-school. Health status and quality of life reported by the parents were very positive at the time of the survey (Summer 2022).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Age-related differences on SARS-CoV-2 sero-immunity could mainly be explained by differences in vaccination rates based on the official German vaccination recommendations as well as differences in SARS-CoV-2 infection rates in the different age groups. Health status and quality of life of almost all children were very good independent of SARS-CoV-2 infection and/or vaccination.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">German Registry for Clinical Trials Identifier W&#xfc;rzburg: DRKS00025546 (registration: 11.09.2021), Bochum: DRKS00022434 (registration:07.08.2020), Dresden: DRKS 00022455 (registration: 23.07.2020).</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Engels</LastName><ForeName>Geraldine</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital W&#xfc;rzburg, Josef-Schneider-Stra&#xdf;e 2, 97080, W&#xfc;rzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oechsle</LastName><ForeName>Anna-Lisa</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Division of Epidemiology, Institute of Social Pediatrics and Adolescent Medicine, LMU Munich, Haydnstra&#xdf;e 5, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlegtendal</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Children's Hospital, Ruhr University of Bochum, Alexandrinenstrasse 5, 44791, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maier</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Children's Hospital, Ruhr University of Bochum, Alexandrinenstrasse 5, 44791, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holzwarth</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany, Fetscherstr. 74, 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Streng</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital W&#xfc;rzburg, Josef-Schneider-Stra&#xdf;e 2, 97080, W&#xfc;rzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lange</LastName><ForeName>Berit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Helmholtz Centre for Infection Research (HZI), Inhoffenstra&#xdf;e 7, 38124, Brunswick, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Infection Research (DZIF), TI BBD, Brunswick, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karch</LastName><ForeName>Andre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Epidemiology and Social Medicine, University of M&#xfc;nster, Albert-Schweitzer-Campus 1, 48149, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petersmann</LastName><ForeName>Astrid</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Clinical Chemistry and Laboratory Medicine, University Oldenburg, Rahel-Straus-Stra&#xdf;e 10, 26133, Oldenburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Clinical Chemistry and Laboratory Medicine, University of Greifswald, Ferdinand-Sauerbruchstrasse, 17475, Greifwald, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Streeck</LastName><ForeName>Hendrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Virology, University Hospital, University of Bonn, Venusberg-Campus 1, Geb&#xe4;ude 63, 53127, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Brunswick, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blaschke-Steinbrecher</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency Department, University Medical Center G&#xf6;ttingen, Robert-Koch Sr. 40, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xe4;rtel</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital W&#xfc;rzburg, Josef-Schneider-Stra&#xdf;e 2, 97080, W&#xfc;rzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroten</LastName><ForeName>Horst</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Pediatric Infectious Diseases, Department of Pediatrics, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Kries</LastName><ForeName>R&#xfc;diger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Epidemiology, Institute of Social Pediatrics and Adolescent Medicine, LMU Munich, Haydnstra&#xdf;e 5, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berner</LastName><ForeName>Reinhard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany, Fetscherstr. 74, 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liese</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital W&#xfc;rzburg, Josef-Schneider-Stra&#xdf;e 2, 97080, W&#xfc;rzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Brinkmann</LastName><ForeName>Folke</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Children's Hospital, Ruhr University of Bochum, Alexandrinenstrasse 5, 44791, Bochum, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of L&#xfc;beck, Campus L&#xfc;beck, Ratzeburger Allee 160, 23538, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Toepfner</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Department of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany, Fetscherstr. 74, 01307, Dresden, Germany. Nicole.Toepfner@uniklinikum-dresden.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>IMMUNEBRIDGE KIDS study group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>01KX2121</GrantID><Agency>Bundesministerium f&#xfc;r Bildung und Forschung</Agency><Country/></Grant><Grant><GrantID>paedSaxCoviDD</GrantID><Agency>Freistaat Sachsen</Agency><Country/></Grant><Grant><GrantID>K3-2484-PN 22-38-V3-D28504/2022</GrantID><Agency>Bavarian State Ministry of Health and Care and the Bavarian Health and Food Safety Authority</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Infection</MedlineTA><NlmUniqueID>0365307</NlmUniqueID><ISSNLinking>0300-8126</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Children and adolescents</Keyword><Keyword MajorTopicYN="N">Omicron</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Seroprevalence</Keyword></KeywordList><CoiStatement>Nicole Toepfner is a member of the directory board of the German Society for Pediatric Infectious Diseases (DGPI). Reinhard Berner is member of the Corona Expert Counsel of the German government, the Expert Advisory Board on pandemic Acute Respiratory Infections of the Robert Koch Institute, pandemic working group of the Standing committee on Vaccination (STIKO), medical pandemic counsel of the German Medical Association, scientific advisory board of the working group &#x201c;long-COVID-syndrome&#x201d; of the German Medical Association, task force Corona for the German Society of Pediatrics and Adolescent Medicine (DGKJ). Berit Lange has received the following grants: egePan Unimed (grant number 01KX2021), NUM COVIM 1.0 (grant number 01KX2021), PREPARED (grant number 01KX2021), RESPINOW (grant number MV2021-012), OptimAgent (grant number MV2021-014). Berit Lange is speaker for the &#x201c;Modeling Network for Severe Infectious Diseases&#x201d;, vice-president of the German Society of Epidemiology (DGEpi) and member of the internal advisory board of the German Center for Infection Research and member of the steering committee of TBNet. Andre Karch has received funding associated with the SARS-CoV-2 pandemic and other infectious epidemiology-related questions from the German Research Foundation, the German Federal Ministry of Education and Research, the German Federal Ministry of Health, the Robert Koch Institute, the &#x201c;Landeszentrum Gesundheit Nordrhein-Westfalen&#x201d;, &#x201c;Nieders&#xe4;chsische Vorab&#x201d; of the Volkswagen Foundation as well as innovation fund of the German federal Joint Committee.Hendrik Streeck has received fees for a discussion round considering &#x201c;science communication&#x201d; from Johnson&amp;Johnson and is part of the scientific advisory board of AstraZeneca and Seqirus without receiving financial compensation. All other authors disclose no further conflicts of interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Forster</LastName><ForeName>Johannes</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurzai</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pietsch</LastName><ForeName>Franziska</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hick</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hecker</LastName><ForeName>Katharina</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>L&#xfc;cke</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwarzbach</LastName><ForeName>Michaela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>H&#xf6;ppner</LastName><ForeName>Jakob</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drinka</LastName><ForeName>Denisa</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Armann</LastName><ForeName>Jakob</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blankenburg</LastName><ForeName>Judith</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Falke</LastName><ForeName>Uta</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schneider</LastName><ForeName>Josephine</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>J&#xe4;ger</LastName><ForeName>Veronika</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>R&#xfc;cker</LastName><ForeName>Viktoria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harries</LastName><ForeName>Manuela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hassenstein</LastName><ForeName>Max</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dreier</LastName><ForeName>Maren</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>von Holt</LastName><ForeName>Isabell</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Budde</LastName><ForeName>Axel</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kurosinski</LastName><ForeName>Marc-Andr&#xe9;</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartz</LastName><ForeName>Antonia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brandhorst</LastName><ForeName>Gunnar</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brinkmann</LastName><ForeName>Melanie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Budde</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deckena</LastName><ForeName>Marek</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fenzlaff</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hovardovska</LastName><ForeName>Olga</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kehl</LastName><ForeName>Katja</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kohls</LastName><ForeName>Mirjam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kr&#xfc;ger</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meyer-Schlinkmann</LastName><ForeName>Kristin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ottensmeyer</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reese</LastName><ForeName>Jens-Peter</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosenkranz</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>R&#xfc;bsamen</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schattschneider</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sch&#xe4;fer</LastName><ForeName>Christin</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schlinkert</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schulze-Wundling</LastName><ForeName>Kai</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>St&#xf6;rk</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tiemann</LastName><ForeName>Carsten</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>V&#xf6;lzke</LastName><ForeName>Henry</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Winter</LastName><ForeName>Theresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heuschmann</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nauck</LastName><ForeName>Matthias</ForeName><Initials>M</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>6</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37280412</ArticleId><ArticleId IdType="pmc">PMC10243264</ArticleId><ArticleId IdType="doi">10.1007/s15010-023-02052-5</ArticleId><ArticleId IdType="pii">10.1007/s15010-023-02052-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Robert Koch Institut: W&#xf6;chentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19). https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2021-12-30.pdf?__blob=publicationFile. Accessed 31.10.2022.</Citation></Reference><Reference><Citation>Edward PR, Lorenzo-Redondo R, Reyna ME, Simons LM, Hultquist JF, Patel AB, et al. Severity of illness caused by severe acute respiratory syndrome coronavirus 2 variants of concern in children: a single-center retrospective cohort study. J Pediatric Infect Dis Soc. 2022;11:440&#x2013;447. doi: 10.1093/jpids/piac068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piac068</ArticleId><ArticleId IdType="pmc">PMC9384683</ArticleId><ArticleId IdType="pubmed">35924454</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguoro I, Pilotto C, Bonanni M, Ferrari ME, Pusiol A, Nocerino A, et al. SARS-COV-2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020;179:1029&#x2013;1046. doi: 10.1007/s00431-020-03684-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-020-03684-7</ArticleId><ArticleId IdType="pmc">PMC7234446</ArticleId><ArticleId IdType="pubmed">32424745</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravens-Sieberer U, Kaman A, Erhart M, Devine J, Schlack R, Otto C. Impact of the COVID-19 pandemic on quality of life and mental health in children and adolescents in Germany. Eur Child Adolesc Psychiatry. 2022;31:879&#x2013;889. doi: 10.1007/s00787-021-01726-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00787-021-01726-5</ArticleId><ArticleId IdType="pmc">PMC7829493</ArticleId><ArticleId IdType="pubmed">33492480</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloete J, Kruger A, Masha M, du Plessis NM, Mawela D, Tshukudu M, et al. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B. 1.1.5.29) variant wave in South Africa: a multicentre observational study. Lancet Child Adolesc. 2022;6:294&#x2013;302. doi: 10.1016/S2352-4642(22)00027-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00027-X</ArticleId><ArticleId IdType="pmc">PMC8856663</ArticleId><ArticleId IdType="pubmed">35189083</ArticleId></ArticleIdList></Reference><Reference><Citation>Ott R, Achenbach P, Ewald DA, Friedl N, Gemulla G, Hubmann M, et al. SARS-CoV-2 Seroprevalence in preschool and school-age children-population screening findings From January 2020 to June 2022. Dtsch Arztebl Int. 2022 doi: 10.3238/arztebl.m2022.0355.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0355</ArticleId><ArticleId IdType="pmc">PMC9884841</ArticleId><ArticleId IdType="pubmed">36345616</ArticleId></ArticleIdList></Reference><Reference><Citation>Engels GHK, Forster J, et al. High seroprevalence of SARS-CoV-2 in preschool children in July 2022&#x2014;a cross-sectional data collection in day-care centers. Dtsch Arztebl Int. 2022 doi: 10.3238/arztebl.m2022.0345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0345</ArticleId><ArticleId IdType="pmc">PMC9884839</ArticleId><ArticleId IdType="pubmed">36700368</ArticleId></ArticleIdList></Reference><Reference><Citation>Armann JPBJ, Czyborra P, et al. SARS-CoV-2 immunity gap among schoolchildren and teachers in the summer of 2022. Dtsch Arztebl Int. 2022 doi: 10.3238/arztebl.m2022.0307.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0307</ArticleId><ArticleId IdType="pmc">PMC9902890</ArticleId><ArticleId IdType="pubmed">36727650</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaballa M-E, Perez-Saez J, de Mestral C, Pullen N, Lamour J, Turelli P, et al. Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA2 wave in Geneva, Switzerland. medRxiv. 2022 doi: 10.1101/2022.07.27.22278126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.07.27.22278126</ArticleId><ArticleId IdType="pmc">PMC9714630</ArticleId><ArticleId IdType="pubmed">36474728</ArticleId></ArticleIdList></Reference><Reference><Citation>Mari A, Garancini N, Barcellini L, Alberti LF, Gaia P, Amendola A, et al. SARS-CoV-2 seroprevalence among school-age children in Milan: how has it changed with the fourth pandemic wave? Pediatr Infect Dis J. 2022;41:e344&#x2013;e345. doi: 10.1097/INF.0000000000003583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003583</ArticleId><ArticleId IdType="pmc">PMC9281415</ArticleId><ArticleId IdType="pubmed">35622423</ArticleId></ArticleIdList></Reference><Reference><Citation>Centre HHPS. Seroprevalence of antibodies to SARS-CoV-2in children aged 1&#x2013;12 years and adults aged 18+ years: results from National Serosurveillance Programme Collection Cycle 1. 2022.</Citation></Reference><Reference><Citation>Wang L, Berger NA, Kaelber DC, Davis PB, Volkow ND, Xu R. COVID infection severity in children under 5 years old before and after Omicron emergence in the USA. medRxiv. 2022;600:577. doi: 10.1101/2022.01.12.22269179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.12.22269179</ArticleId></ArticleIdList></Reference><Reference><Citation>Marks KJ, Whitaker M, Agathis NT, Anglin O, Milucky J, Patel K, et al. Hospitalization of infants and children aged 0&#x2013;4 years with laboratory-confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022. MMWR Morb Mortal Wkly Rep. 2022;71:429&#x2013;436. doi: 10.15585/mmwr.mm7111e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7111e2</ArticleId><ArticleId IdType="pmc">PMC8942304</ArticleId><ArticleId IdType="pubmed">35298458</ArticleId></ArticleIdList></Reference><Reference><Citation>Doenhardt M, Gano C, Sorg AL, Diffloth N, Tenenbaum T, von Kries R, et al. Burden of pediatric SARS-CoV-2 hospitalizations during the Omicron wave in Germany. Viruses. 2022 doi: 10.3390/v14102102.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14102102</ArticleId><ArticleId IdType="pmc">PMC9607436</ArticleId><ArticleId IdType="pubmed">36298657</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt AA, Dargham SR, Loka S, Shaik RM, Chemaitelly H, Tang P, et al. Coronavirus disease 2019 disease severity in children infected with the omicron variant. Clin Infect Dis. 2022;75:e361&#x2013;e367. doi: 10.1093/cid/ciac275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac275</ArticleId><ArticleId IdType="pmc">PMC9047187</ArticleId><ArticleId IdType="pubmed">35404391</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorabawila V, Hoefer D, Bauer UE, Bassett MT, Lutterloh E, Rosenberg ES. Risk of infection and hospitalization among vaccinated and unvaccinated Children and adolescents in New York after the emergence of the omicron variant. J Am Med Assoc. 2022 doi: 10.1001/jama.2022.7319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.7319</ArticleId><ArticleId IdType="pmc">PMC9107062</ArticleId><ArticleId IdType="pubmed">35559959</ArticleId></ArticleIdList></Reference><Reference><Citation>Vygen-Bonnet SKJ, Armann J, et al. Beschluss der STIKO zur 9 Aktualisierung der COVID-19-Impfempfehlung und die dazugeh&#xf6;rige wissenschaftliche Begr&#xfc;ndung. Epid Bull. 2021 doi: 10.25646/8942.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.25646/8942.2</ArticleId></ArticleIdList></Reference><Reference><Citation>Impfkommission S. Beschluss der STIKO zur 22 Aktualisierung der COVID-19-Impfempfehlung. Epid Bull. 2022;40:3&#x2013;20. doi: 10.25646/10656.</Citation><ArticleIdList><ArticleId IdType="doi">10.25646/10656</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe4;ndige Impfkommission. Beschluss der STIKO zur 20. Aktualisierung der COVID-19-Impfempfehlung Epid Bull. 2022; 10.25646/10076.2.</Citation></Reference><Reference><Citation>Forster J, Streng A, Rudolph P, Rucker V, Wallstabe J, Timme S, et al. Feasibility of SARS-CoV-2 surveillance testing among children and childcare workers at German day care centers a nonrandomized controlled trial. JAMA Netw Open. 2022;5:e2142057. doi: 10.1001/jamanetworkopen.2021.42057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.42057</ArticleId><ArticleId IdType="pmc">PMC8728621</ArticleId><ArticleId IdType="pubmed">34982157</ArticleId></ArticleIdList></Reference><Reference><Citation>Engels G, Forster J, Streng A, Rucker V, Rudolph P, Pietsch F, et al. Acceptance of different self-sampling methods for semiweekly SARS-CoV-2 testing in asymptomatic children and childcare workers at german day care centers a nonrandomized controlled trial. JAMA Netw Open. 2022;5:e2231798. doi: 10.1001/jamanetworkopen.2022.31798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.31798</ArticleId><ArticleId IdType="pmc">PMC9478779</ArticleId><ArticleId IdType="pubmed">36107424</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler L, Rigby M. Indicators of children&#x2019;s development: considerations when constructing a set of national child health indicators for the European union. Child Care Health Dev. 2003;29:551&#x2013;558. doi: 10.1046/j.1365-2214.2003.00375.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2214.2003.00375.x</ArticleId><ArticleId IdType="pubmed">14616913</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, Bevans KB, Pratiwadi R, Moon J, Teneralli RE, Minton JM, et al. Development of the PROMIS&#xae; pediatric global health (PGH-7) measure. Qual Life Res. 2014;23:1221&#x2013;1231. doi: 10.1007/s11136-013-0581-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-013-0581-8</ArticleId><ArticleId IdType="pmc">PMC3966936</ArticleId><ArticleId IdType="pubmed">24264804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravens-Sieberer U, Gosch A, Rajmil L, Erhart M, Bruil J, Power M, et al. The KIDSCREEN-52 quality of life measure for children and adolescents: psychometric results from a cross-cultural survey in 13 European countries. Value Health. 2008;11:645&#x2013;658. doi: 10.1111/j.1524-4733.2007.00291.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-4733.2007.00291.x</ArticleId><ArticleId IdType="pubmed">18179669</ArticleId></ArticleIdList></Reference><Reference><Citation>Otto C, Reiss F, Voss C, W&#xfc;stner A, Meyrose AK, H&#xf6;lling H, et al. Mental health and well-being from childhood to adulthood: design, methods and results of the 11-year follow-up of the BELLA study. Eur Child Adolesc Psychiatry. 2021;30:1559&#x2013;1577. doi: 10.1007/s00787-020-01630-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00787-020-01630-4</ArticleId><ArticleId IdType="pmc">PMC8505294</ArticleId><ArticleId IdType="pubmed">32918625</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;lling H, Schlack R, Kamtsiuris P, Butschalowsky H, Schlaud M, Kurth BM. Die KiGGS-studie. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2012;55:836&#x2013;842. doi: 10.1007/s00103-012-1486-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00103-012-1486-3</ArticleId><ArticleId IdType="pubmed">22736165</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski DM, Kaweski SE, Irvine MA, Kim S, Chuang ES, Sabaiduc S, et al. Serial cross-sectional estimation of vaccine and infection-induced SARS-CoV-2 sero-prevalence in children and adults, British Columbia Canada March 2020 to August 2022. Medrxiv. 2022 doi: 10.1101/2022.09.09.22279751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.09.09.22279751</ArticleId><ArticleId IdType="pmc">PMC9828974</ArticleId><ArticleId IdType="pubmed">36507788</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahava MJ, Jarva H, J&#xe4;&#xe4;skel&#xe4;inen AJ, Lappalainen M, Vapalahti O, Kurkela S. Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland. Eur J Clin Microbiol Infect Dis. 2022;41:997&#x2013;999. doi: 10.1007/s10096-022-04448-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-022-04448-x</ArticleId><ArticleId IdType="pmc">PMC9049924</ArticleId><ArticleId IdType="pubmed">35484359</ArticleId></ArticleIdList></Reference><Reference><Citation>Erikstrup C, Laksafoss AD, Gladov J, Kaspersen KA, Mikkelsen S, Hindhede L, et al. Seroprevalence and infection fatality rate of the SARS-CoV-2 omicron variant in Denmark: a nationwide serosurveillance study. Lancet Reg Health Eur. 2022 doi: 10.1016/j.lanepe.2022.100479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100479</ArticleId><ArticleId IdType="pmc">PMC9355516</ArticleId><ArticleId IdType="pubmed">35959415</ArticleId></ArticleIdList></Reference><Reference><Citation>Castilla J, Lecea &#xd3;, Mart&#xed;n Salas C, Qu&#xed;lez D, Miqueleiz A, Trobajo-Sanmart&#xed;n C, et al. Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022. Eurosurveillance. 2022;27:2200619. doi: 10.2807/1560-7917.ES.2022.27.33.2200619.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.33.2200619</ArticleId><ArticleId IdType="pmc">PMC9389855</ArticleId><ArticleId IdType="pubmed">35983774</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange B, J&#xe4;ger V, R&#xfc;cker V, Harries M, Hassenstein M, Dreier M, et al. 2. Interimsanalyse des IMMUNEBRIDGE-Projektes zur Kommunikation von vorl&#xe4;ufigen Ergebnissen an das Modellierungsnetz f&#xfc;r schwere Infektionskrankheiten. https://zenodo.org/record/7177592#.Y242LdaZOM8. Accessed 11.11.2022.</Citation></Reference><Reference><Citation>Impfquote gegen das Coronavirus in Deutschland nach Altersgruppe. https://de.statista.com/statistik/daten/studie/1258043/umfrage/impfquote-gegen-das-coronavirus-in-deutschland-nach-altersgruppe/. Accessed 31.10.2022.</Citation></Reference><Reference><Citation>https://www.ema.europa.eu/en/news/ema-recommends-approval-comirnaty-spikevax-covid-19-vaccines-children-6-months-age. Accessed 09.11.2022.</Citation></Reference><Reference><Citation>Koch JPV, Vygen-Bonnet S, et al. Wissenschaftliche Begr&#xfc;ndung der STIKO f&#xfc;r die COVID-19-Impf-empfehlung f&#xfc;r Kinder im Alter von 6 Monaten bis 4 Jahren sowie zur Anpassung der COVID-19-Impf-empfehlung f&#xfc;r Kinder im Alter von 5&#x2013;11 Jahre. Epid Bull. 2022;46:22&#x2013;47.</Citation></Reference><Reference><Citation>Meherali S, Punjani N, Louie-Poon S, Abdul Rahim K, Das JK, Salam RA, et al. Mental health of children and adolescents amidst COVID-19 and past pandemics: a rapid systematic review. Int J Environ Res Public Health. 2021 doi: 10.3390/ijerph18073432.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18073432</ArticleId><ArticleId IdType="pmc">PMC8038056</ArticleId><ArticleId IdType="pubmed">33810225</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira JMD, Butini L, Pauletto P, Lehmkuhl KM, Stefani CM, Bolan M, et al. Mental health effects prevalence in children and adolescents during the COVID-19 pandemic: a systematic review. Worldviews Evid Based Nurs. 2022;19:130&#x2013;137. doi: 10.1111/wvn.12566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/wvn.12566</ArticleId><ArticleId IdType="pmc">PMC9115455</ArticleId><ArticleId IdType="pubmed">35229967</ArticleId></ArticleIdList></Reference><Reference><Citation>Elharake JA, Akbar F, Malik AA, Gilliam W, Omer SB. Mental health impact of COVID-19 among children and college students: a systematic REVIEW. Child Psychiat Hum D. 2022 doi: 10.1007/s10578-021-01297-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10578-021-01297-1</ArticleId><ArticleId IdType="pmc">PMC8747859</ArticleId><ArticleId IdType="pubmed">35013847</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauhanen L, Yunus WMAWM, Lempinen L, Peltonen K, Gyllenberg D, Mishina K, et al. A systematic review of the mental health changes of children and young people before and during the COVID-19 pandemic. Eur Child Adoles Psy. 2022 doi: 10.1007/s00787-022-02060-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00787-022-02060-0</ArticleId><ArticleId IdType="pmc">PMC9373888</ArticleId><ArticleId IdType="pubmed">35962147</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>